Thermotherapy via targeted delivery of nanoscale magnetic particles
CA 2453676 C · Owner: Foreman, Allan · Inventors: Foreman, Allan; Handy, Erik S.; Gwost, Douglas U.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are therapeutic methods for the treatment of diseased disease-, causing, or undesirable tissue or material that involve the administration of a thermotherpeutic magnetic composition which contains single-domain magnetic particles attached to a target-specific ligand to a patient and the , application of an alternating magnetic field to inductively heat the thermotherapeutic magnetic composition. Also disclosed are methods for administration of the thermotherapeutic magnetic composition. These therapeutic methods may be used where the predetermined target is associated with a disease, such as cancer, diseases of the immune system pathogen-borne , diseases, obesity, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 25, 2002 and granted October 2, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 25, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 25, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.